These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34685767)

  • 1. Hormonally Induced Hepatocellular Carcinoma in Diabetic Wild Type and Carbohydrate Responsive Element Binding Protein Knockout Mice.
    Nuernberger V; Mortoga S; Metzendorf C; Burkert C; Ehricke K; Knuth E; Zimmer J; Singer S; Nath N; Karim M; Yasser M; Calvisi DF; Dombrowski F; Ribback S
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular glycogenotic foci after combined intraportal pancreatic islet transplantation and knockout of the carbohydrate responsive element binding protein in diabetic mice.
    Ribback S; Sonke J; Lohr A; Frohme J; Peters K; Holm J; Peters M; Cigliano A; Calvisi DF; Dombrowski F
    Oncotarget; 2017 Nov; 8(61):104315-104329. PubMed ID: 29262643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a.
    Lei Y; Hoogerland JA; Bloks VW; Bos T; Bleeker A; Wolters H; Wolters JC; Hijmans BS; van Dijk TH; Thomas R; van Weeghel M; Mithieux G; Houtkooper RH; de Bruin A; Rajas F; Kuipers F; Oosterveer MH
    Hepatology; 2020 Nov; 72(5):1638-1653. PubMed ID: 32083759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. V-AKT murine thymoma viral oncogene homolog/mammalian target of rapamycin activation induces a module of metabolic changes contributing to growth in insulin-induced hepatocarcinogenesis.
    Evert M; Calvisi DF; Evert K; De Murtas V; Gasparetti G; Mattu S; Destefanis G; Ladu S; Zimmermann A; Delogu S; Thiel S; Thiele A; Ribback S; Dombrowski F
    Hepatology; 2012 May; 55(5):1473-84. PubMed ID: 22271091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular and metabolic changes in human clear cell liver foci].
    Ribback S; Calvisi DF; Cigliano A; Rausch J; Heidecke CD; Birth M; Dombrowski F
    Pathologe; 2015 Nov; 36 Suppl 2():210-5. PubMed ID: 26483250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
    Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
    Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and metabolic changes in human liver clear cell foci resemble the alterations occurring in rat hepatocarcinogenesis.
    Ribback S; Calvisi DF; Cigliano A; Sailer V; Peters M; Rausch J; Heidecke CD; Birth M; Dombrowski F
    J Hepatol; 2013 Jun; 58(6):1147-56. PubMed ID: 23348238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogene-dependent addiction to carbohydrate-responsive element binding protein in hepatocellular carcinoma.
    Ribback S; Che L; Pilo MG; Cigliano A; Latte G; Pes GM; Porcu A; Pascale RM; Li L; Qiao Y; Dombrowski F; Chen X; Calvisi DF
    Cell Cycle; 2018; 17(12):1496-1512. PubMed ID: 29965794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of hepatic carbohydrate response element binding protein (ChREBP) impairs glucose homeostasis and hepatic insulin sensitivity in mice.
    Jois T; Chen W; Howard V; Harvey R; Youngs K; Thalmann C; Saha P; Chan L; Cowley MA; Sleeman MW
    Mol Metab; 2017 Nov; 6(11):1381-1394. PubMed ID: 29107286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Islet ChREBP-β is increased in diabetes and controls ChREBP-α and glucose-induced gene expression via a negative feedback loop.
    Jing G; Chen J; Xu G; Shalev A
    Mol Metab; 2016 Dec; 5(12):1208-1215. PubMed ID: 27900263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression.
    Dentin R; Pégorier JP; Benhamed F; Foufelle F; Ferré P; Fauveau V; Magnuson MA; Girard J; Postic C
    J Biol Chem; 2004 May; 279(19):20314-26. PubMed ID: 14985368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism.
    Fisher FM; Kim M; Doridot L; Cunniff JC; Parker TS; Levine DM; Hellerstein MK; Hudgins LC; Maratos-Flier E; Herman MA
    Mol Metab; 2017 Jan; 6(1):14-21. PubMed ID: 28123933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice.
    Linden AG; Li S; Choi HY; Fang F; Fukasawa M; Uyeda K; Hammer RE; Horton JD; Engelking LJ; Liang G
    J Lipid Res; 2018 Mar; 59(3):475-487. PubMed ID: 29335275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome.
    Iizuka K; Horikawa Y
    Endocr J; 2008 Aug; 55(4):617-24. PubMed ID: 18490833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preneoplastic glycogenotic lesions of the liver and kidney : Metabolic and molecular alterations in preneoplastic clear cell lesions of the liver and the kidney in experimental and human carcinogenesis].
    Ribback S
    Pathologe; 2020 Dec; 41(Suppl 2):83-90. PubMed ID: 33346873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
    Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
    Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERα down-regulates carbohydrate responsive element binding protein and decreases aerobic glycolysis in liver cancer cells.
    Lu Y; Tian N; Hu L; Meng J; Feng M; Zhu Y; Zhang P; Li M; Liu Q; Tong L; Tong X; Li Y; Wu L
    J Cell Mol Med; 2021 Apr; 25(7):3427-3436. PubMed ID: 33656238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Nogo expression inhibits diet-induced metabolic disorders by regulating ChREBP and insulin activity.
    Zhang S; Guo F; Yu M; Yang X; Yao Z; Li Q; Wei Z; Feng K; Zeng P; Zhao D; Li X; Zhu Y; Miao QR; Iwakiri Y; Chen Y; Han J; Duan Y
    J Hepatol; 2020 Dec; 73(6):1482-1495. PubMed ID: 32738448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Hepatic Transcription Factor EB Attenuates Alcohol-Associated Liver Carcinogenesis.
    Chao X; Wang S; Hlobik M; Ballabio A; Ni HM; Ding WX
    Am J Pathol; 2022 Jan; 192(1):87-103. PubMed ID: 34717896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ChREBP plays a pivotal role in the nutrient-mediated regulation of metabolic gene expression in brown adipose tissue.
    Baek S; Seo DS; Kang J; Ahmad Y; Park S; Joo S; Kim K; Jang Y
    Life Sci; 2024 Aug; 351():122843. PubMed ID: 38880168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.